Replies to post #132668 on Elite Pharmaceuticals Inc (ELTP)

[Hike]

According to IMS Health, the 2013 U.S. market for opioid analgesics was $8.3 billion. Of this, extended release opioids accounted for approximately $4.3 billion. The market leader, controlled release oxycodone (primarily OxyContin®) had annual sales of $2.5 billion in 2013 (IMS Health).

So ...$20 billion "worldwide" seems plausible to me.

[no2koolaid]

Since it is your data that is in question, you should offer links in support of your position that it is not $20 Billion and growing at 4% CAGR.